Sensei Biotherapeutics doses patients in tumour therapy trial

US-based biotechnology company Sensei Biotherapeutics has dosed the first patient in a Phase I/II clinical trial of SNS-101 to treat …

Clearside opens enrolment in Phase IIb trial of wet AMD therapy

US-based biopharmaceutical company Clearside Biomedical has begun enrolling patients in its Phase IIb trial of CLS-AX (axitinib injectable suspension). The multi-centre …

Hookipa debuts Phase I/II data

Hookipa Pharma  has reported preliminary positive data and trial updates from its ongoing phase II study of HB-200 in combination …

NeuroMetrix encouraged by Phase II Quell data

NeuroMetrix is gearing up to present partial trial results on Quell, the company’s wireless transcutaneous electric nerve stimulation (TENS) device, …

Adiso completes Phase Ib MAD study of UC therapy

Adiso Therapeutics has completed a Phase Ib multiple ascending dose (MAD) trial of ADS051 (BT051) for the treatment of moderate-to-severe …